Company / Working Capital per Share
NovoCure Ltd Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$3.90
FY2025
5-year range
$3.27 / $9.16
FY2021-FY2025
Trend
+19.3%
vs FY2024
Sector context
#103 of 163
Health Care
What the data says
At $3.90, NovoCure Ltd's working capital per share ranks #103 of 163 in the Health Care sector. Working Capital per Share returned to growth in FY2025 after 2 years of decline, reaching $3.90.
Based on SEC 10-K filings.
3.90 in FY2025 with a 5-year CAGR of -15.2%.
Declined from $8.14 to $3.90 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -24.8%
- 5-Year CAGR
- -15.2%
- 10-Year CAGR
- -
Sector benchmark
#103 of 163 in Health CareTop 63% of 163This company $3.90 Sector average $24.09
▼
-83.8% below sector average
Key checks
Key Insights
- In FY2025, working capital per share increased 19.3% year-over-year.
- Ranks #103 out of 163 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2022.
- Lowest working capital per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.90 | +19.3% |
| FY2024 | $3.27 | -59.8% |
| FY2023 | $8.14 | -11.2% |
| FY2022 | $9.16 | +0.7% |
| FY2021 | $9.10 | +2.2% |
| FY2020 | $8.90 | +134.7% |
| FY2019 | $3.79 | +32.1% |
| FY2018 | $2.87 | +28.2% |
| FY2017 | $2.24 | -16.6% |
| FY2016 | $2.69 | -86.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026